Formulation and evaluation of mucoadhesive glipizide microspheres

The purpose of this research was to formulate and system-atically evaluate in vitro and in vivo performances of mucoadhesive microspheres of glipizide. Glipizide microspheres containing chitosan were prepared by simple emulsification phase separation technique using glutaraldehyde as a cross-linking agent. Results of preliminary trials indicate that volume of cross-linking agent, time for cross-linking, polymer-to-drug ratio, and speed of rotation affected characteristics of microspheres. Microspheres were discrete, spherical, and free flowing. The microspheres exhibited good mucoadhesive property in the in vitro wash-off test and also showed a high percentage drug entrapment efficiency. A 32 full factorial design was employed to study the effect of independent variables, polymer-to-drug ratio (X1), and stirring speed (X2) on dependent variables percentage mucoadhesion, t80, drug entrapment efficiency, and swelling index. The best batch exhibited a high drug entrapment efficiency of 75% and a swelling index of 1.42; percentage mucoadhesion after 1 hour was 78%. The drug release was also sustained for more than 12 hours. The polymer-to-drug ratio had a more significant effect on the dependent variables. In vivo testing of the mucoadhesive microspheres to albino Wistar rats demonstrated significant hypoglycemic effect of glipizide.

[1]  I. El-Gibaly.  Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres. , 2002, International journal of pharmaceutics.

[2]  Ge Jiang,et al.  Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone , 2008, AAPS PharmSciTech.

[3]  M. Gohel,et al.  Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[4]  G. Smistad,et al.  Bioadhesion of hydrated chitosans: An in vitro and in vivo study , 1996 .

[5]  C. P. Sharma,et al.  Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. , 1997, Journal of biomedical materials research.

[6]  A. Jayakrishnan,et al.  Cross‐linked Chitosan Microspheres: Preparation and Evaluation as a Matrix for the Controlled Release of Pharmaceuticals , 1992, The Journal of pharmacy and pharmacology.

[7]  R. Hatcher.  THE UNITED STATES PHARMACOPEIA. , 1908 .

[8]  G. L. Plosker,et al.  Glipizide , 2000, PharmacoEconomics.

[9]  J. Robinson,et al.  Bioadhesive-based dosage forms: the next generation. , 2000, Journal of pharmaceutical sciences.

[10]  S. H. Fox.  The Theory and Practice of Industrial Pharmacy , 1970 .

[11]  H. Junginger,et al.  Intestinal transit of bioadhesive microspheres in an in situ loop in the rat—A comparative study with copolymers and blends based on poly(acrylic acid) , 1990 .

[12]  K. Murata,et al.  Enhancement of bioavailability of dopamine via nasal route in beagle dogs. , 1992, Chemical & pharmaceutical bulletin.

[13]  K. Chowdary,et al.  Design And Evaluation Of Mucoadhesive Controlled Release Oral Tablets Of Glipizide , 2003 .

[14]  W. Cefalu,et al.  Comparative Efficacy of a Once-Daily Controlled-Release Formulation of Glipizide and Immediate-Release Glipizide in Patients With NIDDM , 1994, Diabetes Care.

[15]  R. Parikh,et al.  Two-stage optimization process for formulation of chitosan microspheres , 2004, AAPS PharmSciTech.

[16]  S. Davis,et al.  Nasal administration of gentamicin using a novel microsphere delivery system , 1988 .

[17]  T. Ohno,et al.  Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres , 1997 .

[18]  M. Patel,et al.  Formulation And Optimization Of Mucoadhesive Microspheres Of Metoclopramide , 2004 .

[19]  A. Thombre,et al.  Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Claus-Michael Lehr,et al.  In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers , 1992 .

[21]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1976 .

[22]  J. Carstensen,et al.  Release mechanisms in gelforming sustained release preparations , 1979 .

[23]  Nagai Tsuneji,et al.  Powder dosage form of insulin for nasal administration , 1984 .

[24]  Ge Jiang,et al.  Preparation and Characterization of a Composite PLGA and Poly(Acryloyl Hydroxyethyl Starch) Microsphere System for Protein Delivery , 2001, Pharmaceutical Research.

[25]  K. Chowdary,et al.  Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: A technical note , 2003, AAPS PharmSciTech.

[26]  L. Y. Wang,et al.  Determination of time course of tablet disintegration II: Method using continuous functions. , 1978, Journal of pharmaceutical sciences.

[27]  J. Hardman,et al.  Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas , 2001 .

[28]  Jagdish Singh,et al.  Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres , 2000, AAPS PharmSciTech.

[29]  S. Garg,et al.  Bioadhesive microspheres as a controlled drug delivery system. , 2003, International journal of pharmaceutics.

[30]  T. Chandy,et al.  Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. , 1996, Journal of microencapsulation.